Latest News

Morinaga Milk’s probiotic B. breve A1 improves memory functions of older adults with MCI

Morinaga Milk Industry Co., Ltd., a leading Japanese dairy product company and a key global probiotics manufacturer, confirmed that its proprietary probiotic strain Bifidobacterium breve A1 (a.k.a. B. breve MCC1274) is safe and effective for improving memory functions of older adults with suspected mild cognitive impairment (MCI) in a randomized, double-blind, placebo-controlled trial (RCT).

Source link

Related posts

Coronavirus Daily Digest: May 20, 2020


Study reveals fresh insights into how new disease-causing strains of bacteria emerge


The truth about JPM: Less is more


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World